Actinogen Medical LimitedASX: ACW

AGM date and closing date for director nominations

Oct 8, 2026 at 6:10 PM EDT · Issued by Actinogen Medical Limited via ASX

Filed with ASX · Oct 8, 2026 at 6:10 PM EDT

On 6ix: 6ix.com/news/agm-date-and-closing-date-for-director-nominations-4

Actinogen Medical Limited ACN 086 778 476 Suite 901, Level 9, 109 Pitt Street, Sydney NSW 2000 +61 2 8964 7401 | actinogen.com.au 1 ASX ANNOUNCEMENT AGM date and closing date for director nominations Sydney, 9 October 2026. Actinogen Medical ASX: ACW (‘ACW’ or ‘the Company’) advises, in...

View Attachment

6ix hasn’t read this filing yet.

Actinogen Medical Limited on 6ix

Earlier from Actinogen Medical

Application for quotation of securities - ACWSep 29
Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for NovemberSep 23
Underwriting of unlisted options completedSep 22
Options underwriting cleansing noticeSep 22
ACW Alzheimers pivotal trial completes last patient visitSep 22

Later from Actinogen Medical

Notification of buy-back - ACWOct 11
ACW September 2026 quarterly activity report & Appendix 4COct 18
ACW pivotal Alzheimers trial database lock - results mid-NovOct 20
Actinogen receives $10.8m R&D tax incentive rebate from ATOOct 25
Letter to Shareholders, Notice of AGM & Proxy FormOct 27

All Actinogen Medical news releases

Follow Actinogen Medical into a list and get an email when it puts out news.

Follow Actinogen Medical